Connection

Jean Nappi to Female

This is a "connection" page, showing publications Jean Nappi has written about Female.
Connection Strength

0.141
  1. Barriers to clopidogrel adherence following placement of drug-eluting stents. Ann Pharmacother. 2009 Feb; 43(2):259-67.
    View in: PubMed
    Score: 0.018
  2. Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatment. Pharmacotherapy. 2007 May; 27(5):707-14.
    View in: PubMed
    Score: 0.016
  3. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Pharmacotherapy. 2006 Apr; 26(4):461-8.
    View in: PubMed
    Score: 0.015
  4. Role of race in the pharmacotherapy of heart failure. Ann Pharmacother. 2002 Mar; 36(3):471-8.
    View in: PubMed
    Score: 0.011
  5. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother. 2001 May; 35(5):589-617.
    View in: PubMed
    Score: 0.010
  6. Myocardial infarction in women: a critical appraisal of gender differences in outcomes. Pharmacotherapy. 2000 Sep; 20(9):1034-44.
    View in: PubMed
    Score: 0.010
  7. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch Intern Med. 1999 Mar 08; 159(5):511-3.
    View in: PubMed
    Score: 0.009
  8. Pharmacy residency training measured through a standardized knowledge test. Am J Health Syst Pharm. 2016 Dec 15; 73(24):2095-2098.
    View in: PubMed
    Score: 0.008
  9. Possible pharmacokinetic interaction with quinidine: ciprofloxacin or metronidazole? Ann Pharmacother. 1996 Apr; 30(4):364-6.
    View in: PubMed
    Score: 0.007
  10. Multi-institutional study of women and underrepresented minority faculty members in academic pharmacy. Am J Pharm Educ. 2012 Feb 10; 76(1):7.
    View in: PubMed
    Score: 0.006
  11. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011 Dec; 55(12):5475-9.
    View in: PubMed
    Score: 0.005
  12. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. J Card Fail. 2010 Mar; 16(3):188-93.
    View in: PubMed
    Score: 0.005
  13. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis. Ann Pharmacother. 2008 Jun; 42(6):904-5.
    View in: PubMed
    Score: 0.004
  14. Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias. Eur J Clin Pharmacol. 1986; 31(1):15-22.
    View in: PubMed
    Score: 0.004
  15. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Am J Cardiol. 1984 Feb 01; 53(4):522-7.
    View in: PubMed
    Score: 0.003
  16. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine. J Cardiovasc Pharmacol. 1983 Mar-Apr; 5(2):213-20.
    View in: PubMed
    Score: 0.003
  17. Combination antiplatelet therapy: implications for pharmacists. J Am Pharm Assoc (Wash). 2002 Nov-Dec; 42(6):880-3.
    View in: PubMed
    Score: 0.003
  18. Antihypertensive monotherapy with tablet (prompt-release) diltiazem: multicenter controlled trials. Cardiovasc Drugs Ther. 1990 Aug; 4(4):1089-96.
    View in: PubMed
    Score: 0.001
  19. Sustained-release diltiazem: duration of antihypertensive effect. J Clin Pharmacol. 1989 Jun; 29(6):533-7.
    View in: PubMed
    Score: 0.001
  20. Metabolic effects of antihypertensive therapy with a calcium antagonist. Am J Cardiol. 1988 Oct 05; 62(11):109G-113G.
    View in: PubMed
    Score: 0.001
  21. The disposition of recainam hydrochloride during and after intravenous loading and maintenance infusion in cardiac patients. J Clin Pharmacol. 1987 Dec; 27(12):951-6.
    View in: PubMed
    Score: 0.001
  22. Individualization of phenytoin dosage regimens. Clin Pharmacol Ther. 1977 Mar; 21(3):287-93.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.